From: Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation
 | End-stage liver disease patients | |||
---|---|---|---|---|
Child A | Child B | Child C | P value | |
N=79 | N=43 | N=77 | Â | |
Age | 60 a (55–64) | 55b (51–60) | 52c (48.50–57) | <0.001 HS |
Hb.% | 12.5 a (11–13.70) | 12 b (10.70–13) | 12b (11–13) | 0.031 |
WBCsX103 | 5.30 a (4.30–6.50) | 5.10 a (4–6) | 5.60 a (4–6.95) | 0.6 |
PlateletsX103 | 130 b (96–160) | 156 ab (90–180) | 165 a (121–210) | <0.001 HS |
ALT | 43 a (34–50) | 40 a (33–47) | 46 a (30–110) | 0.09 |
AST | 52 a (45–63) | 48 a (29–65) | 46 a (21.5–86.5) | 0.509 |
Alb. | 3.50 b (3.20–3.80) | 3.40 b (2.80–3.80) | 3.80 a (3.45–4.00) | <0.001 HS |
Creat. | 1.00 a (0.90–1.10) | 1.00 a (0.90–1.10) | 1.00 a (0.90–1.10) | 0.86 |